Autoimmune diabetes prevention and reversal by anti-CD20 therapy

被引：0
|
作者：
Hu, C. Y. [1 ]
Rodrigue-Pinto, D. [1 ]
Du, W. [1 ]
Ahnja, A. [2 ]
Wong, F. S. [3 ]
Shlonichik, M. [2 ]
Wen, L. [1 ]
机构：
[1] Yale Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT USA
[2] Yale Sch Med, Dept Lab Med, Immunol Sect, New Haven, CT USA
[3] Univ Bristol, Dept Cellular & Mol Med, Bristol BS8 1TH, Avon, England
来源：
ACTA DIABETOLOGICA | 2007年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria
    Arkwright, Peter D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 510 - 511
  • [2] Anti-CD20 therapy and autoimmune disease: Therapeutic opportunities and evolving insights
    Silverman, Gregg J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2194 - 2206
  • [3] Anti-CD20 Therapy in NOD Model of Type 1 Diabetes
    Hu, Changyun
    Rodriguez, Daniel
    Du, Wei
    Ahuja, Anupama.
    Wong, F. Susan
    Shlomchik, Mark
    Wen, Li
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [4] Combination Treatment With Anti-CD20 and Oral Anti-CD3 Prevents and Reverses Autoimmune Diabetes
    Hu, Changyun
    Ding, Heynan
    Zhang, Xiaojun
    Wong, F. Susan
    Wen, Li
    DIABETES, 2013, 62 (08) : 2849 - 2858
  • [5] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
  • [6] Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria Reply
    Kaplan, Allen P.
    Joseph, Kusumam
    Maykut, Robert J.
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 511 - 511
  • [7] Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin
    Biswas, Moanaro
    Rogers, Geoffrey L.
    Sherman, Alexandra
    Byrnes, Barry J.
    Markusic, David M.
    Jiang, Haiyan
    Herzog, Roland W.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) : 33 - 43
  • [8] B Cell Targeting Therapy Using the Anti-CD20 Antibody in Autoimmune Diseases
    Tanaka, Yoshiya
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (06): : 675 - 679
  • [9] Anti-CD20 therapy in rheumatoid arthritis
    Roll, P.
    Tony, H. -P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 370 - +
  • [10] Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?
    Mc Mahon, C
    Babu, L
    Hodgson, A
    Hayat, A
    Connell, NO
    Smith, OP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 480 - 482
12345